Last reviewed · How we verify

NCT04480775: triamcinolone

Triamcinolone Versus Methylprednisolone in Transversus Abdominis Plane Block

Completed Phase 2, PHASE3 Last updated 3 March 2021
What this trial tests

Phase 2, PHASE3 trial testing Triamcinolone in Major Abdominal Surgery in 84 participants. Completed in 15 December 2020.

Timeline
15 July 2020
Primary endpoint
15 December 2020
15 December 2020

Quick facts

Lead sponsorghada fouad
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment84
Start date15 July 2020
Primary completion15 December 2020
Estimated completion15 December 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

ghada fouad — full company profile →

Who can join

Adults 20 to 60, any sex, with Major Abdominal Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In the current Study we will compare between triamcinolone and methylprednisolone as an additive to bupivacaine drug in ultrasound guided TAP block in major open abdominal surgery .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Triamcinolone

Trials testing the same drug.

Other ghada fouad trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04480775.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing